Correlation of polymorphic variation in the promoter region of the interleukin‐1β gene with secretion of interleukin‐1β protein

Objective Significant variation in interleukin-1β (IL-1β) protein secretion between subjects has been observed when using a lipopolysaccharide (LPS)/ATP–mediated ex vivo blood stimulation assay. To explore the potential relationships between genetic polymorphisms in the IL1B cytokine gene and cellular responses to inflammatory stimuli such as LPS, we investigated the hypothesis that polymorphisms within the promoter and exon 5 of the IL1B gene contribute to the observed differences in IL-1β protein secretion. Methods The IL1B gene polymorphisms C−511T, T−31C, and C3954T were tested for association with LPS-induced secretion of IL-1β protein as measured by an ex vivo blood stimulation assay. Samples from 2 independent study populations (n = 31 and n = 25) were available for use in the ex vivo assay after consent was obtained to analyze the DNA. Results A specific haplotype, composed of the T allele at −511 and the C allele at −31, was significantly associated with a 2–3-fold increase in LPS-induced IL-1β protein secretion. This association was observed in both of the independent study populations (P = 0.0084 and P = 0.0017). Conclusion These data suggest that polymorphisms within the promoter region of the IL1B gene contribute to observed differences in LPS-induced IL-1β protein secretion.

[1]  P. Slagboom,et al.  Association of the interleukin-1 gene cluster with radiographic signs of osteoarthritis of the hip. , 2004, Arthritis and rheumatism.

[2]  Leif E. Peterson,et al.  Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection , 2002 .

[3]  T. Perneger,et al.  Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[4]  A. Lefvert,et al.  Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes. , 2002, The Journal of rheumatology.

[5]  K. Matsuo,et al.  Interleukin 1 Polymorphisms, Lifestyle Factors, and Helicobacter pylori Infection , 2001, Japanese journal of cancer research : Gann.

[6]  J. Sieper,et al.  Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritis. , 2000, Arthritis and rheumatism.

[7]  N. Camp,et al.  An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. , 2000, The Journal of infectious diseases.

[8]  C. Gabel,et al.  ATP Acts as an Agonist to Promote Stimulus-Induced Secretion of IL-1β and IL-18 in Human Blood , 2000, The Journal of Immunology.

[9]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[10]  Association of early‐onset Alzheimer's disease with an interleukin‐1α gene polymorphism , 2000, Annals of neurology.

[11]  L. Peltonen,et al.  Genome scan for predisposing loci for distal interphalangeal joint osteoarthritis: evidence for a locus on 2q. , 1999, American journal of human genetics.

[12]  A. Silman,et al.  Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. , 1999, Human molecular genetics.

[13]  B. Mazières,et al.  Interleukin‐1β, interleukin‐1 receptor antagonist, interleukin‐4, and interleukin‐10 gene polymorphisms: Relationship to occurrence and severity of rheumatoid arthritis , 1999 .

[14]  C. Gabel,et al.  Human monocyte interleukin-1beta posttranslational processing. Evidence of a volume-regulated response. , 1996, The Journal of biological chemistry.

[15]  C. Gabel,et al.  Tenidap and other anion transport inhibitors disrupt cytolytic T lymphocyte-mediated IL-1 beta post-translational processing. , 1996, Journal of immunology.

[16]  Laurent Excoffier,et al.  Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm , 1996, Heredity.

[17]  J. Crusius,et al.  Allelic polymorphism in IL‐1β and IL‐1 receptor antagonist (IL‐1Ra) genes in inflammatory bowel disease , 1995, Clinical and experimental immunology.

[18]  Jurg Ott,et al.  Handbook of Human Genetic Linkage , 1994 .

[19]  G. Duff,et al.  A Physical Map of the Region Encompassing the Human Interleukin-1α, Interleukin-1β, and Interleukin-1 Receptor Antagonist Genes , 1994 .

[20]  C. Gabel,et al.  IL-1 beta maturation: evidence that mature cytokine formation can be induced specifically by nigericin. , 1992, Journal of immunology.

[21]  F. Pociot,et al.  A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro , 1992 .

[22]  C. March,et al.  Molecular cloning of the interleukin-1 beta converting enzyme. , 1992, Science.

[23]  E. Unanue,et al.  Interleukin 1 is processed and released during apoptosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F. Cozzolino,et al.  A novel secretory pathway for interleukin‐1 beta, a protein lacking a signal sequence. , 1990, The EMBO journal.

[25]  C. J. Dunn,et al.  Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein , 1990, Nature.

[26]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[27]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[28]  A. C. Webb,et al.  Interleukin-1 gene (IL1) assigned to long arm of human chromosome 2. , 1986, Lymphokine research.

[29]  C. March,et al.  Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs , 1985, Nature.

[30]  A. C. Webb,et al.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. , 1984, Proceedings of the National Academy of Sciences of the United States of America.